Skip to main content
EUDA
NASDAQ Industrial Applications And Services

EUDA Health Launches Regenixé iPSC-Derived Skin Stem Cell Secretome Mask, Expanding Helixé Product Line

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$18.06
Mkt Cap
$45.048M
52W Low
$5.26
52W High
$86
52W Position info
243% above low
Off High info
79% below high
Rel. Volume
Market data snapshot near publication time

EUDA has more than doubled off its 52-week low of $5.26.

Summary

EUDA Health announced the launch of its new Regenixé iPSC-derived Skin Stem Cell Secretome Mask, expanding its Helixé product line and targeting the growing beauty and wellness market in Asia-Pacific.


Key Events · Product Development and Regulatory · EUDA

  • New Product Launch

    EUDA Health launched the Regenixé iPSC-derived Skin Stem Cell Secretome Mask, a beauty product developed by Chemokine Pte Ltd.

  • Product Line Expansion

    The new mask expands the company's Helixé product line, for which EUDA holds exclusive global distributorship rights.

  • Market Opportunity

    The product targets the global face mask market, estimated at approximately $7.95 billion in 2026 and growing, with a focus on the Asia-Pacific region.

  • Strategic Distribution

    EUDA intends to leverage its established distribution networks in Malaysia and China to drive sales and expand the Helixé product line.


Analysis · EUDA · Industrial Applications And Services

This filing announces the launch of a new beauty product, the Regenixé iPSC-derived Skin Stem Cell Secretome Mask, expanding EUDA Health's Helixé product line. For a company with a relatively small market capitalization and recent compliance challenges, a new product launch with exclusive global distribution rights in a growing multi-billion dollar market (face masks) represents a positive step towards revenue generation and improving its financial position. It demonstrates active business development and a strategy to leverage its distribution networks in Asia-Pacific.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 29.9% of the 1678 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.25%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, EUDA was trading at $18.06 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $45M. The 52-week trading range was $5.26 to $86.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

EUDA - Latest Insights

EUDA
Jul 28, 2026, 4:30 PM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $19.90
Real-time Price: $16.95 info
Change: -$2.95 (-15%) info
Market Cap: $50.754M info
EUDA
Jul 28, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $19.00
Real-time Price: $16.95 info
Change: -$2.05 (-11%) info
Market Cap: $50.754M info
EUDA
Jun 10, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $15.46
Real-time Price: $16.95 info
Change: +$1.49 (+10%) info
Market Cap: $50.754M info
EUDA
Jun 01, 2026, 7:30 AM EDT
Filing Type: 6-K
Importance Score:
9
Price at Filing: $18.06
Real-time Price: $16.95 info
Change: -$1.11 (-6%) info
Market Cap: $50.754M info
EUDA
Jun 01, 2026, 6:05 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $18.06
Real-time Price: $16.95 info
Change: -$1.11 (-6%) info
Market Cap: $50.754M info